ME

Mary Elizabathe Joseph

Director DIN 01041958
DIN 01041958 First appointment Aug 2003
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Mary Elizabathe Joseph

Data last updated:

Mary Elizabathe Joseph was a Director at Indigene Pharmaceuticals Private Limited (from 2003) and Director at Indigene Biopharmaceuticals (India) Private Limited (from 2011).

DIN 01041958
First Appointment 20 Aug 2003
Oldest Company Age 24 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20032002Strike Off
Director28 Jun 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indigene Pharmaceuticals Private Limited
Indigene Biopharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Mary Elizabathe Joseph

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mary Elizabathe Joseph

Mary Elizabathe Joseph was first appointed on 20 Aug 2003 as Director at Indigene Pharmaceuticals Private Limited. The most recent appointment on record is 28 Jun 2011 at Indigene Biopharmaceuticals (India) Private Limited.

Mary Elizabathe Joseph held 2 earlier board appointments: Indigene Pharmaceuticals Private Limited (Director, from 20 Aug 2003); Indigene Biopharmaceuticals (India) Private Limited (Director, from 28 Jun 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available